FR2273516A1 - Agent de diagnostic pour l'administration intravasculaire - Google Patents

Agent de diagnostic pour l'administration intravasculaire

Info

Publication number
FR2273516A1
FR2273516A1 FR7517632A FR7517632A FR2273516A1 FR 2273516 A1 FR2273516 A1 FR 2273516A1 FR 7517632 A FR7517632 A FR 7517632A FR 7517632 A FR7517632 A FR 7517632A FR 2273516 A1 FR2273516 A1 FR 2273516A1
Authority
FR
France
Prior art keywords
intravascular administration
diagnosis agent
diagnosis
agent
intravascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7517632A
Other languages
English (en)
French (fr)
Other versions
FR2273516B1 (cg-RX-API-DMAC7.html
Inventor
Ulf Sven Erik Rothman
Bernt Jabes Lindberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of FR2273516A1 publication Critical patent/FR2273516A1/fr
Application granted granted Critical
Publication of FR2273516B1 publication Critical patent/FR2273516B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7517632A 1974-06-06 1975-06-05 Agent de diagnostic pour l'administration intravasculaire Granted FR2273516A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (2)

Publication Number Publication Date
FR2273516A1 true FR2273516A1 (fr) 1976-01-02
FR2273516B1 FR2273516B1 (cg-RX-API-DMAC7.html) 1979-01-05

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7517632A Granted FR2273516A1 (fr) 1974-06-06 1975-06-05 Agent de diagnostic pour l'administration intravasculaire

Country Status (8)

Country Link
JP (1) JPS517113A (cg-RX-API-DMAC7.html)
AU (1) AU8164675A (cg-RX-API-DMAC7.html)
CA (1) CA1039274A (cg-RX-API-DMAC7.html)
DE (1) DE2524278A1 (cg-RX-API-DMAC7.html)
FR (1) FR2273516A1 (cg-RX-API-DMAC7.html)
GB (1) GB1518813A (cg-RX-API-DMAC7.html)
NL (1) NL7506743A (cg-RX-API-DMAC7.html)
SE (1) SE420566B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548902A1 (fr) * 1983-07-13 1985-01-18 Guerbet Sa Gel pour embolisation therapeutique

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548902A1 (fr) * 1983-07-13 1985-01-18 Guerbet Sa Gel pour embolisation therapeutique
EP0133391A1 (fr) * 1983-07-13 1985-02-20 Guerbet S.A. Composition pour embolisation thérapeutique

Also Published As

Publication number Publication date
NL7506743A (nl) 1975-12-09
AU8164675A (en) 1976-12-02
GB1518813A (en) 1978-07-26
FR2273516B1 (cg-RX-API-DMAC7.html) 1979-01-05
SE7407461L (sv) 1975-12-08
SE420566B (sv) 1981-10-19
CA1039274A (en) 1978-09-26
JPS517113A (cg-RX-API-DMAC7.html) 1976-01-21
DE2524278A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
FR2273555A1 (fr) Agent d'administration intravasculaire
BE834265A (fr) Ensemble d'electrode de diagnostic
FR2312224A1 (fr) Dispositif de diagnostic medical
FR2280706A1 (fr) Concentres d'agents de nettoyage
FR2304084A1 (fr) Agent de diagnostic pour la detection d'albumine dans des liquides physiologiques
FR2284303A1 (fr) Douille de trocart pour l'endoscopie de cavites corporelles
BE768791A (fr) Injecteur intra-uterin pour diagnostic
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2303292A1 (fr) Systeme reactif de diagnostic
FR2352285A1 (fr) Appareil de mesure d'ecoulement, notamment pour le diagnostic medical
NL7507057A (nl) Tandreinigingsmiddel.
NL7503732A (nl) Ultrasone inrichting voor medische diagnose.
GB1445964A (en) Diagnostic agent for the detection of glucose in urine
BE816927A (fr) Support impregne pour le diagnostic des affections hepatiques
BE864030Q (fr) Agent de diagnostic pour la recherche de la bilirubine
FR2296220A1 (fr) Echelle de diagnostic pour l'interpretation d'un electrocardiogramme
BE813400A (fr) Reduction de l'oxyde de nickel
FR2311303A1 (fr) Agent de diagnostic pour detecter l'urobilinogene
FR2322576A1 (fr) Appui-tete pour examens ophtalmologiques
HK16278A (en) Diagnostic agent
BE806667A (fr) Agent de contraste pour examens radiologiques
BE816925A (fr) Support impregne pour le diagnostic de l'homocystinurie et de la cystinurie
BE834266A (fr) Ensemble d'electrode de diagnostic
FR2280085A1 (fr) Composition et procede pour le diagnostic de brucelloses
FR2305725A1 (fr) Systemes de diagnostic pour vehicules

Legal Events

Date Code Title Description
ST Notification of lapse